Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Celltrion
Biotech
Moderna
AbbVie
Topics

Advertisement

Advertisement

Celltrion

Share

Top Latest Popular

NewsNow Essentials. Better browsing, ad free. Just £4/m, billed annually. Upgrade now!

NewsNow Essentials. Your favourite news platform, ad free. £4/m, billed annually. Upgrade now!

Yesterday

Celltrion seeks rheumatoid arthritis indication expansion for Zymfentra Asia Today 07:45 Wed, 23 Sep

Tuesday

Celltrion clears European quality hurdle with Songdo plant certification The Korea Times 04:23 Tue, 22 Sep

Celltrion renews EU-GMP certification for 250,000-liter Songdo facilities Korea Biomedical Review 02:55 Tue, 22 Sep

Advertisement

Advertisement

In the last month

Celltrion files for US phase 4 trial of 240 mg Zymfentra dose Korea Biomedical Review 06:01 Tue, 15 Sep

Spotlight On: Biosimilar Litigations - September 2026 JD Supra 20:29 Mon, 14 Sep

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) / Zimrixby™... JD Supra 19:49 Mon, 14 Sep

Celltrion targets wider European growth for Omlyclo after gains in Spain, Italy Korea Biomedical Review 07:23 Thu, 10 Sep

Celltrion steps up European push for asthma drug Omlyclo The Korea Herald 07:14 Thu, 10 Sep

Celltrion’s Omlyclo gains ground in major European markets, tops 90% share in Spain Asia Today 05:18 Thu, 10 Sep

Chasing 13 new drugs, Celltrion takes startup hunt to 3 continents Korea Biomedical Review 05:06 Tue, 08 Sep

Celltrion’s Steqeyma reaches 16.2% share of US ustekinumab market: IQVIA Korea Biomedical Review 01:46 Thu, 03 Sep

Celltrion’s SC infliximab franchise nears halfway mark toward ₩1tri. won sales target Korea Biomedical Review 02:51 Thu, 27 Aug

Celltrion Expands Omlyclo® Portfolio in Europe with Launch of 300 mg Strength Business Wire (Press Release) 23:43 Mon, 24 Aug

Advertisement

My Local News

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna